In brief: Chaga (Inonotus obliquus) grows mainly on birch and is sold as tea, powder or extract. Laboratory and animal research is interesting, but it does not replace clinical evidence in humans.
What is actually established?
| Claim | Interpretation |
|---|---|
| Antioxidant laboratory activity | Described |
| Cancer treatment | Not clinically established |
| Blood-sugar lowering | No reliable human treatment evidence |
| Immune boosting | No robust general recommendation |
Oxalate and kidney risk
A published case report described end-stage renal disease after long-term use of large amounts of Chaga powder; the tested product had very high oxalate content.[1] This does not prove every serving is dangerous, but it shows why high-dose long-term use can be problematic.
Possible interactions
Extra caution is sensible with kidney disease, oxalate stones, anticoagulants or glucose-lowering medicines. Safety data in pregnancy and breastfeeding are insufficient.
FAQ
Is Chaga a cancer medicine?
No. Clinical evidence is lacking.
Can Chaga damage the kidneys?
High and prolonged intake may be problematic because of oxalate.
Is tea safer than extract?
Composition differs; safety cannot be assumed from the form alone.
Can Chaga affect medicines?
Possibly, particularly anticoagulant and glucose-lowering medicines.
Conclusion
Chaga is traditionally interesting but not a proven immune or cancer treatment. Kidney risk and possible interactions deserve more attention than marketing claims.
